S H Kelkar and Company Limited (NSE:SHK)
162.05
-2.56 (-1.56%)
Feb 17, 2026, 3:30 PM IST
S H Kelkar and Company Revenue
S H Kelkar and Company had revenue of 5.84B INR in the quarter ending December 31, 2025, with 7.96% growth. This brings the company's revenue in the last twelve months to 22.82B, up 6.05% year-over-year. In the fiscal year ending March 31, 2025, S H Kelkar and Company had annual revenue of 21.19B with 15.43% growth.
Revenue (ttm)
22.82B
Revenue Growth
+6.05%
P/S Ratio
1.00
Revenue / Employee
35.93M
Employees
635
Market Cap
22.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 21.19B | 2.83B | 15.43% |
| Mar 31, 2024 | 18.36B | 1.54B | 9.15% |
| Mar 31, 2023 | 16.82B | 1.18B | 7.54% |
| Mar 31, 2022 | 15.64B | 2.42B | 18.32% |
| Mar 31, 2021 | 13.22B | 2.08B | 18.64% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Savita Oil Technologies | 41.44B |
| Rossari Biotech | 22.91B |
| Veedol Corporation | 20.94B |
| Jubilant Agri and Consumer Products | 18.04B |
| NOCIL | 13.12B |
| Neogen Chemicals | 8.18B |
| Advanced Enzyme Technologies | 7.10B |
| Jai Corp | 6.63B |
S H Kelkar and Company News
- 3 months ago - S H Kelkar shares fall nearly 6% today after Q2 FY26 profit drops 77% - Business Upturn
- 9 months ago - S H Kelkar shares surge nearly 10% after Q4 net profit hits Rs 102.5 crore - Business Upturn
- 11 months ago - S H Kelkar reports 15% YoY revenue growth to Rs 2,110 crore in FY25, expects margin recovery in FY26 - Business Upturn
- 1 year ago - S H Kelkar & Company shares decline over 4% as Q3 net profit falls 45.61% YoY - Business Upturn
- 1 year ago - SH Kelkar stock falls over 7% today amid Gross margins pressures - Business Upturn